p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
暂无分享，去创建一个
M. Brizzi | A. Bottini | L. Dogliotti | A. Berruti | A. Bersiga | G. Gorzegno | L. Filippini | E. Betri | S. Aguggini | G. Bertoli | P. Alquati | F. Cirillo | A. Brunelli | B. Dimarco | G. Bolsi | B. DiMarco | Luciano Filippini